have the capacity to function as nonprofessional antigen presenting cells that in the normal state preferentially activate CD8ϩ T cells. However, under pathological conditions, such as those found in inflammatory bowel disease (IBD), persistent activation of CD4ϩ T cells is seen. The aim of this study was to determine whether the IBD IECs contribute to CD4ϩ T cell activation. Freshly isolated human IECs were obtained from surgical specimens of patients with or without IBD and cocultured with autologous or allogeneic peripheral blood T lymphocytes. Cocultures of normal T cells and IECs derived from IBD patients resulted in the preferential activation of CD4ϩ T cell proliferation that was associated with significant IFN-␥, but not IL-2, secretion. Cytokine secretion and CD4ϩ T cell proliferation was inhibited by pretreatment of the IBD IECs with the anti-DR MAb L243. In contrast, normal IECs stimulated the proliferation and cytokine secretion by CD4ϩ T cells to a significantly lesser degree than IBD IECs. Furthermore, blockade of human leukocyte antigen-DR had a lesser effect in the normal IEC-CD4ϩ T cell cocultures. We conclude that IECs can contribute to the ongoing CD4ϩ T cell activation seen in IBD. We suggest that the apparent differences between the secreted levels of IFN-␥ indicate that it may play a dual role in intestinal homeostasis, in which low levels contribute to physiological inflammation whereas higher levels are associated with an uncontrolled inflammatory state. mucosal inflammation; Crohn's disease; ulcerative colitis; interferon-␥; cytokines INFLAMMATORY BOWEL DISEASE (IBD) is a chronic inflammatory intestinal disorder of unknown etiology comprised of two phenotypes: Crohn's disease (CD) and ulcerative colitis (UC). Although the precise cause of inflammation is as yet undefined, it is believed that an antigen-driven response against nonpathogenic bowel flora is one of the initial events (15, 49) . This has been clearly demonstrated in animal models of IBD (13, 52, 57) and has been suggested in human disease (4, 6, 7, 11, 54, 60) . Unlike the normal state, in which an immunological response toward normal bowel flora and food antigens has been proposed to mediate controlled, "physiological," inflammation, in IBD inflammation is uncontrolled. The inflammatory cells and mediators responsible for such loss of control are as yet unknown.
Murine models of IBD demonstrate that CD4ϩ T cell differentiation plays a pivotal role in determining the type of immune response generated in the gut and that distinct cytokine profiles characterize each CD4ϩ T cell subset (Th1, Th2, Th3/Tr1) (3, 9, 10, 26, 45) . In humans, however, these distinctions are not as clear and extrapolation from animal models is not straightforward (55) . In Crohn's disease, a Th1 CD4ϩ T cell differentiation pathway is responsible for macrophage activation, granuloma formation and increased tissue levels of TNF-␣ (41, 47, 50, 51) . For IFN-␥ and IL-2, however, conflicting data exist, as both increased and decreased levels of these cytokines have been reported under various conditions (19, 21, 37) . In UC, the cytokine profile is even less defined. Attempts to demonstrate a clear Th2 cytokine profile have failed. The only cytokines reported to be consistently increased are IL-5, IFN-␥, and, recently, IL-13 (18, 19, 42) . The role of regulatory Th3/Tr1 cells (8, 62) , generally associated with tolerance, has not yet been defined in IBD, and both increased (28) and decreased (20) IL-10 levels have been reported.
What initiates the aberrant activation of CD4ϩ T cells in IBD? Aberrant antigen presentation by professional antigen presenting cells (APC) such as monocytes and dendritic cells has been suggested (24, 33, 35, 58, 61) . However, recent work from our laboratory and others has pointed to a possible role of the intestinal epithelial cell in the activation of CD4ϩ T cells in IBD. The constitutive expression of major histocompatibility complex (MHC) class II molecules on IECs and their increased expression in IBD (39) make the direct interaction of IECs with CD4ϩ T cells a realistic possibility. Moreover, the demonstration of CD58 and CD86 on IECs in normal (17) and in IBD (UC) patients (44) , respectively, and of B7H on normal as well as IBD IECs (22, 43) suggests that these cells are able to deliver costimulatory signals, thereby initiating active immunity. In the microenvironment of the IECs, however, costimulation may be less critical, because the vast majority of lamina propria lymphocytes (LPLs) are memory cells (56, 59) . The demonstration, by Hershberg's group (17, 23) , of direct activation of CD4ϩ T cell clones by DRϩ IEC lines and our own work demonstrating activation of CD4ϩ associated p56-lck by IBD IECs (63) strongly support the IEC's potential as a direct activator of CD4ϩ T cells.
When normal IECs are used as APCs, activation of CD8ϩ T cells is seen (2, 40, 63) . This occurs through the IEC surface molecules gp180 (CD8 ligand) and CD1d, which associate and form a MHC class I-like complex (40) that stimulates CD8ϩ T cell activation, which is reflected in T cell proliferation (34, 48, 66) . In IBD, gp180's expression is decreased (63) , so stimulation of CD8ϩ suppressor T cells does not occur (5) , and the delicate balance between CD8ϩ T cell suppression and CD4ϩ T cell active immunity could be skewed toward the latter. As data suggesting a possible direct interaction between IECs and CD4ϩ T cells have accumulated, we hypothesized that such direct interactions may occur in the normal gut but would be elevated in IBD, thus contributing to CD4ϩ T cell overactivity. To address this hypothesis, we compared the proliferation and cytokine secretion profiles of CD4ϩ T cells that were cocultured with fresh human IECs from normal and IBD tissues. In this study we demonstrate that IBD IECs preferentially stimulate CD4ϩ T cells in vitro resulting in their proliferation and in IFN-␥ secretion. We also show that MHC class II molecules, whose expression is increased on IBD IECs, are involved in the mediation of this interaction.
METHODS

Isolation of IECs
Surgical specimens were obtained from colonic resections performed at the Mount Sinai Medical Center. Forty-five IEC:peripheral blood T cell (PBT cell) cocultures were generated. IECs were obtained from 18 normal mucosal samples (at least 10 cm distal to colonic malignancies) 13 CD, 10 UC, and 4 diverticulitis (non-IBD inflammatory control) patients.
IECs were isolated by a method described previously (38) . Briefly, specimens were washed with PBS, and the mucosa was stripped from the submucosa and placed in 1 mM dithiothreitol (Sigma, St. Louis, MO) for 10 min. The pieces were then washed with PBS and incubated twice in dispase (Boehringer Mannheim, Indianapolis, IN), 3 mg/ml in RPMI 1640 medium (Mediatech Cellgro, Herndon, VA), for 30 min in a 37°C water bath. The cell suspension was collected and centrifuged on a Percoll density gradient. IECs are located at the 0 -30% layer interface. Cells were washed three times with RPMI and resuspended in serum free medium (AIM-V, 50 U/ml penicillin, 50 g/ml streptomycin, 2 mM glutamine all from GIBCO BRL, Grand Island, NY) for coculture experiments. Cells were Ͼ95% viable by Trypan blue exclusion, and the purity of IECs in the suspension was Ͼ95%, as determined by staining with FITC-conjugated antiepithelial cell-specific antigen (ESA, Biomeda) and flow cytometric analysis using Cell Quest software. IEC preparations were irradiated (3,000 rads) before coculture with T cells.
Isolation of Peripheral Blood T Cell Subpopulations
Peripheral blood CD3ϩ, CD4ϩ, CD8ϩ, or whole T cells were negatively selected from normal donor blood by the RosetteSep procedure (StemCell Technologies, Vancouver, Canada) according to the manufacturer's instructions. In brief, tetrameric antibody complexes directed against glycophorin A on red blood cells and against cell surface markers on human hematopoietic cells (anti-CD16, CD19, CD36, CD56, and anti-CD4 or anti-CD8) were added to whole blood (50 l/ml) and incubated at room temperature. After 20 min, samples were diluted with PBS-2% FBS, layered over Ficoll-Paque (Amersham Pharmacia Biotech, Uppsala, Sweden) and centrifuged for 20 min (the unwanted cells pellet along with the red blood cells). The interface was collected, washed twice with PBS-2% FBS and resuspended in serum-free medium (Aim-V). The purity of CD4ϩ and CD8ϩ T cell suspensions was Ͼ98% with Ͻ1% CD8ϩ contamination in CD4ϩ T cell suspension and vice versa, as determined by flow cytometric analysis.
Coculture Assays
A total of 1 ϫ 10 6 IECs from normal or IBD patients were cocultured with 1 ϫ 10 6 allogeneic whole T cells, or CD4ϩ or CD8ϩ T cells in AIM-V medium, in a total volume of 1 ml/well in 24-well flat-bottom plates (Falcon, BD Biosciences, San Jose, CA). Plates were incubated in a 37°C, 5% CO 2 humidified incubator for 5 days. In each experiment, IECs, whole T cells, and CD4ϩ and CD8ϩ T cells were incubated alone (negative control) or with conventional APCs (non-T cells, positive control). Cell-free supernatants were harvested 36 and 120 h after incubation and frozen at Ϫ70°C until ELISA assays were performed. In several experiments, IECs from normal and IBD patients were cocultured with allogeneic normal peripheral blood T cells generated from the same donor. In yet another series of experiments, normal and IBD IECs were incubated with autologous or allogeneic peripheral blood T cells (including crossover studies, in which IECs from a normal donor were cocultured with IBD peripheral blood T cells).
Proliferation Assessment
Membrane labeling of T cells with CFSE. Prior to the coculture assays, CD4ϩ, CD8ϩ and whole T cells were resuspended in PBS at 5 ϫ 10 6 /ml and stained with carboxyfluorescein diacetate succinimidyl ester (CFSE) (Molecular Probes, Eugene, OR). Cells were incubated for 10 min at 37°C with 1 mM (final concentration) CFSE, washed twice with RPMI, and used in the coculture experiments.
Flow cytometric analysis. Labeling of T cells with CFSE was performed before cocultures. Five days after incubation, T cells were resuspended in PBS and incubated for 30 min with antibodies. The following antibodies were used: anti-CD3, anti-CD4, and anti-CD8 (conjugated with phycoerythrin, peridinin chlorophyll protein, or APC) and relevant isotype controls (all from Becton Dickinson, San Jose, CA). T cell proliferation was assessed by flow cytometry and four-color analysis of CD3ϩ lymphocytes using Cell Quest software (Becton Dickinson). Nonproliferating cells remain high in CFSE (CFSE-high). In contrast, CFSE expression of proliferating cells decreases in proportion to the number of cell divisions (CFSE-low). After gating on CD3ϩ cells, the percentages of CD4ϩ and CD4Ϫ as well as those of CFSE-high and CFSE-low cells were determined. The data obtained by this approach were confirmed by standard [ 3 H]thymidine incorporation assays. ELISAs. IFN-␥, IL-2, and IL-10 production by cocultured T cells was determined by cytokine ELISA sets purchased from BD-Pharmingen (San Diego, CA). ELISA protocols were used according to the manufacturers' instructions.
RT-PCR. A total of 1 g of RNA, extracted with Trizol reagent 24 -36 h after stimulation of T cells with IECs, was used from each well for cDNA synthesis. Reverse transcription was performed with Moloney murine leukemia virus reverse transcriptase at 42°C for 1 h in a total volume of 30 l. The reaction was stopped by heat inactivation and the cDNA was diluted to 100 l. For each PCR reaction, 2.5 l cDNA, 10 pM of forward and reverse primer, platinum Taq 0.2u with the supplied buffer, and 2 mM MgCl2 and 200 M dNTPs were used in a 25-l final volume. The PCR cycle was 4 min at 95°C to activate the enzyme, then 94°C for 45 s, 60°C for 45 s, and 72°C for 1 min for 30 cycles followed by 10-min extensions at 72°C.
The following primers were used (27) : IFN-␥, 5Ј primer 5Ј-AT-GAAATATACAAGTTATATCTTGGCTTT-3Ј, 3Ј primer 5Ј-GATGCT-CTTCGACCTCGAAACAGCAT-3Ј; ␤-actin, 5Ј primer 5Ј-TGACGGG-GTCACCCACACTGTGCCCATCTA-3Ј, 3Ј primer 5Ј-CTAGAAGCAT-TGCGGTGGACGATGGAGGG-3Ј.
Blocking assays. In some experiments, before the coculture, IECs were incubated with a purified blocking anti-DR monoclonal antibody (L243, ATCC, Rockville, MD) at 35 g/ml for 1 h at 4°C, or an isotype control (monoclonal antibody 204-IgG2b anti-B cell differentiation factor, which is not expressed by IECs). The cells were then washed twice with PBS and resuspended in AIM-V medium for coculture experiments. An aliquot of these IECs was stained by phycoerythrin-conjugated L243 (BD-Pharmingen) to assess human leukocyte antigen (HLA)-DR expression on fresh IECs. These cells were counterstained with FITC-conjugated ESA to confirm that HLA-DR expression was restricted to IECs. Nonviable IECs were excluded by propidium-iodide staining. HLA-DR expression was determined by flow-cytometry using Cell Quest software (Becton Dickinson).
Statistical Analysis
We used two-sample paired t-tests of the means for comparisons between cytokine concentrations originating from the same specimen. For all other comparisons, we used the Mann-Whitney test. P values of Ͻ0.05 were considered to represent statistical significance.
RESULTS
IECs From IBD Patients Preferentially Stimulate CD4ϩ T Cell Proliferation
First we analyzed the effect of IECs from IBD or normal control patients on the proliferative responses of T cells. Nonstimulated T cells (incubated in medium only) had Ͻ1% spontaneous proliferation (Fig. 1A) . Normal IECs promoted higher CD4Ϫ (CD8ϩ) T cell proliferation; the percentages of CD4Ϫ and CD4ϩ CFSE-low (proliferating) T cells were 5.3 Ϯ 1.2 and 2.4 Ϯ 0.4%, n ϭ 7, respectively (P ϭ 0.04). In contrast, IBD IECs promoted significantly higher CD4ϩ vs. CD4Ϫ T cell proliferation; in CD cocultures, the percentages of CD4ϩ and CD4Ϫ CFSE-low (proliferating) T cells were 10.4 Ϯ 2.2 and 3.5 Ϯ 0.9%, respectively (n ϭ 6, P ϭ 0.009), and in UC cocultures the percentages of CD4ϩ and CD4Ϫ CFSE-low (proliferating) T cells were 10.2 Ϯ 3.6 and 7.6 Ϯ 3.4%, respectively (n ϭ 5, P ϭ 0.02). When CD4ϩ T cell proliferation was compared between IBD and normal-IECstimulated cocultures, there was a higher proliferation of CD4ϩ T cells in IBD IECs T-cell cocultures (CD vs. normal P ϭ 0.002, UC vs. normal P ϭ 0.04) (Fig. 2) .
We then determined whether IECs would affect T cell proliferation when normal or IBD IECs were cocultured with pure CD4ϩ T cells. CD4ϩ T cells were negatively selected from whole blood of healthy volunteers. These were Ͼ98% CD3ϩ CD4ϩ and did not proliferate when incubated alone (Fig. 3) . As seen in Figs. 3 and 4, normal IECs had the potential to directly interact with CD4ϩ T cells and to stimulate CD4ϩ T cell proliferation. This was more pronounced in IBD IECstimulated cocultures. The percentage of CD4ϩ CFSE-low (proliferating) T cells in CD IEC:CD4ϩ T cell cocultures was 13.4 Ϯ 1.9% (n ϭ 7, P ϭ 0.001 vs. normal) and 19.5 Ϯ 7.2% in UC cocultures (n ϭ 4, P ϭ 0.02 vs. normal) vs. 3.3 Ϯ 1.3% in normal IEC:CD4ϩ T cell cocultures (n ϭ 6). Non-T cells induced even higher CD4ϩ T cell proliferation (21.7 Ϯ 3.2%, n ϭ 9, P ϭ 0.03). To validate the CFSE data, as well as to quantitate the magnitude of the proliferative response, an alternate approach to measuring cell proliferation, i.e., [ 3 H]thymidine incorporation, was used. In normal IEC-stimulated cocultures, mean CD4ϩ T cell proliferation was 5,864 Ϯ 1,980 cpm (n ϭ 22). This increased to 7,837 Ϯ 1,966 cpm (n ϭ 18) when CD IECs were the stimulator cells (P ϭ 0.003 vs. normal) and to 17,450 Ϯ 6,147 cpm (n ϭ 11) when UC IECs were the stimulator cells (P Ͻ 0.00008 vs. normal, Fig. 5 ). This suggests that immunologically significant proliferative responses of CD4ϩ T cells may be evoked by IECs and that these responses are significantly increased when IBD IECs are the stimulator cells.
Since we have previously shown that the CD8ϩ T cells proliferating in normal IECs:PBT cell cocultures are restricted by a complex of CEA and CD1d (7), one would predict that T cell responses to allogeneic vs. autologous IECs would be roughly comparable. CD1d is nonpolymorphic with a limited repertoire of antigens that are capable of binding into the antigen binding groove (lipids or glycolipids). As seen in Figs. 6 and 7, T cell proliferation in response to autologous vs. allogeneic IECs was comparable (P ϭ not significant). This was true when normal as well as IBD IECs were the stimulating cells (Fig. 6 , normal, 3 different experiments; Fig. 7, CD, representing 3 different  experiments) , and was demonstrated both by [ 3 H]thymidine as well as CFSE assessments of proliferation. This proliferation, however, was still lower than the response to allogeneic monocytes/dendritic cells.
The question that remains is whether there is an intrinsic defect in PBT cells from IBD patients to respond to normal IECs (i.e., is the defect at the level of the T cell or the IEC). To address this directly we established crossover cocultures of normal IECs with CFSE-labeled T cells from normal and IBD patients. As seen in Fig. 7 , T cells, whether from normal subjects or IBD patients, proliferated similarly in all cocultures. Moreover, supporting the data presented thus far, normal IECs evoked a moderate proliferative response in allogeneic CD PBT cells that was comparable to normal autologous PBT cell proliferation. In the crossover experiment CD IECs elicited a higher proliferative response in normal PBT cells, this being comparable to the proliferative response of autologous CD PBT cells. These data suggest that IBD T cells are intrinsically similar to normal control PBT cells in their response to normal IECs.
CD4ϩ T Cells That Are Stimulated By IBD IECs Secrete More IFN-␥ Than Normal IEC-Stimulated CD4ϩ T Cells
We then determined whether the preferential stimulation of CD4ϩ T cell proliferation by IBD IECs was accompanied by a difference in cytokine production. In preliminary kinetic studies we observed an increase in IFN-␥ secretion, above background, starting at 24 -48 h after incubation and reaching a plateau at days 5-6. Thus, IFN-␥ concentrations were determined at two points in time (36 and 120 h). IECs and nonstimulated CD4ϩ or CD8ϩ T cells incubated alone secreted Ͻ40 pg/ml IFN-␥ throughout the incubation period. There was no significant difference between IFN-␥ secretion seen in normal and IBD IECs (control for contaminating intraepithelial lymphocytes) or by CD4ϩ or CD8ϩ T cells alone used in the different cocultures. At 36 h, IFN-␥ secretion by CD4ϩ T cells cocultured with normal IECs was similar to background levels. However, at 120 h an increase to a mean concentration of 205.6 Ϯ 54.9 pg/ml was observed (P ϭ 0.008 vs. 36 h). In contrast, IBD IECs stimulated significantly higher IFN-␥ secretion by CD4ϩ T cells. At 36 h, the IFN-␥ concentration in CD, UC, and normal IEC:CD4ϩ T cell cocultures was 249 Ϯ 80.7 (n ϭ 10), 216.4 Ϯ 60.5 (n ϭ 8), and 28.8 pg/ml (n ϭ 12), respectively (P ϭ 0.01 for CD vs. normal and 0.002 for UC vs. normal). This increased secretion persisted in both CD and UC vs. normal IEC-stimulated cocultures over a 5-day period (Fig. 8A) . Fig. 3 . Purified CD4ϩ T cell proliferation induced by normal, CD, or UC IECs. IECs from IBD or normal mucosa were cocultured with allogeneic CD4ϩ T cells that were purified by negative selection from whole blood of healthy volunteers. Purified CD4ϩ T cell preparations were Ͼ98% CD3ϩCD4ϩ. Proliferation was assessed 5-6 days after incubation by flow cytometry. Viable lymphocytes were gated by their forward and side scatter properties and then separated into CFSE-high (nonproliferating) vs. CFSE-low (proliferating) CD3ϩCD4ϩ T cells. A representative example of 9 independent experiments is depicted. At 120 h, the IFN-␥ concentration in CD, UC, and normal IEC:CD4ϩ T cell cocultures was 1,014 Ϯ 238, 1,139 Ϯ 263.4, and 205.6 Ϯ 54.9 pg/ml, respectively (P ϭ 0.001 for CD vs. normal and 0.0005 for UC vs. normal). Interestingly, this secretion was ϳ80% of the maximal IFN-␥ secretion stimulated by professional APCs (non-T cells). IFN-␥ secretion by CD4ϩ T cells stimulated by IECs from four patients with diverticulitis was Ͻ150 pg/ml at 120 h (data not shown). The ELISA results were supported by IFN-␥ mRNA expression, assessed by RT-PCR (see Fig. 12 ). These results suggest that the difference between normal and IBD cocultures is not merely kinetic, but that the signal for IFN-␥ secretion induced by IBD IECs is stronger than the one induced by normal IECs. We next determined whether CD8ϩ T cells stimulated by normal or IBD IECs also contribute to the overall production of IFN-␥. As seen in Fig. 8B , in contrast to IEC-stimulated CD4ϩ T cells (Fig. 8A) , CD8ϩ T cells secreted low concentrations of IFN-␥ (Ͻ200 pg/ml) whether stimulated by normal, CD, or UC IECs. When CD4ϩ and CD8ϩ T cells from the same healthy donor were stimulated by the same IEC preparation, IFN-␥ secretion by the stimulated CD4ϩ T cells after 120 h was 2.4 higher than the stimulated CD8ϩ T cells in the normal cocultures, five times higher in UC cocultures (P ϭ 0.002 vs. normal), and 15 times higher in CD cocultures (P ϭ 0.008 vs. normal), suggesting a greater contribution to IFN-␥ secretion by CD8ϩ T cells in the normal IECstimulated cocultures (Fig. 8C) .
The different PBT cell preparations that are used in the cocultures may have different responses in allogeneic cocultures. To directly compare the effect of IECs from normal and IBD patients, CD4ϩ T cells from the same healthy donor were incubated simultaneously with IECs from normal or IBD patients. As demonstrated in Fig. 9 , CD4ϩ T cells proliferate more and expressed and secreted more IFN-␥ when IBD IECs (compared with normal IECs) were the stimulator cells.
Interleukin-2 Secretion
To determine whether the increase in IFN-␥ production by IBD IECs stimulated CD4ϩ T cells paralleled a more classic Comparable results were generated in CD IECs auto/allo T cell cocultures using CFSE (see Fig. 7 ). P ϭ not significant. Th1 cytokine profile, IL-2 secretion was measured in the same coculture supernatants. IL-2 levels at 120 h in normal, CD, and UC cocultures were 34 Ϯ 10.2, 66.4 Ϯ 39, and 185.3 Ϯ 77 pg/ml, respectively (Table 1) (P ϭ not significant). When CD4ϩ T cells were stimulated by conventional APCs (non-T cells), maximal stimulation resulted in IL-2 levels of 864 Ϯ 199 pg/ml at 120 h (P ϭ 0.02 vs. normal IEC-induced IL-2 secretion by CD4ϩ T cells).
IFN-␥ concentrations that were secreted in the same normal, CD, and UC cocultures were 205.6 Ϯ 54.9, 1,014 Ϯ 238, and 1,139 Ϯ 263.4 pg/ml, respectively, and 1,556 Ϯ 90 in non-Tstimulated CD4ϩ T cell cocultures. Thus IEC-stimulated IFN-␥ secretion by CD4ϩ T cells is relatively higher than the corresponding value for IL-2.
IL-10 Secretion
IL-10 is an anti-inflammatory/inhibitory cytokine secreted by regulatory T cells, IECs, and macrophages (53) . Its presence or absence in IEC:T cell cocultures could help to explain the observed differences in cytokine secretion profiles. Low (Ͻ35 pg/ml) IL-10 levels were demonstrated in all cocultures (Table 1) , compared with concentrations of 340 Ϯ 170 pg/ml at 120 h, observed when CD4ϩ T cells were maximally stimulated by conventional APCs (non-T cells) (P ϭ 0.03 vs. normal IEC-induced IL-10 secretion by CD4ϩ T cells).
Increased Stimulation of CD4ϩ T Cells by IBD IECs Is Mediated by HLA-DR
The data described suggest that direct interactions between IECs and CD4ϩ T cells do occur and induce CD4ϩ T cell proliferation and IFN-␥ secretion. In previous studies, increased HLA-DR expression on IBD IECs and a low constitutive HLA-DR expression on normal IECs was demonstrated (39) . Therefore, we hypothesized that HLA-DR molecules, which are a prerequisite for the interaction of APCs and CD4ϩ T cells, could mediate the interaction of IECs with CD4ϩ T cells. HLA-DR expression was determined by staining freshly isolated human IECs from normal and IBD tissues with an anti-HLA-DR MAb (L243). From 2.5 to 5.5% [mean fluorescence intensity (MFI) ϭ 32 Ϯ 11] of normal IECs expressed HLA-DR. In contrast, 45-97% of CD (MFI ϭ 1,052 Ϯ 406) and 34 -62% (MFI ϭ 385 Ϯ 114) of UC IECs expressed HLA-DR. Not only was the percentage of stained cells significantly higher in IBD, but the density of expression was also significantly higher ( Table 2 ). The HLA-DR expression on IECs from non-IBD inflammatory controls was similar to that seen on normal IECs (Fig. 10) . To assess the contribution of HLA-DR to IEC:CD4ϩ T cell interactions, IECs were incubated with the anti-HLA-DR blocking monoclonal antibody L243 or an isotype control MAb, washed, and cocultured with CD4ϩ T cells. Because IFN-␥ secretion was reproducibly demonstrated in IEC:CD4ϩ T cell cocultures, we used IFN-␥ secretion as a measure of CD4ϩ T cell stimulation by IECs. Preincubation of IECs with MAb L243, but not with an isotype control, significantly decreased IFN-␥ secretion in the cocultures by 80% (UC) to 99% (CD) (Fig. 11, B and C) . IFN-␥ mRNA expression, assessed by RT-PCR, supported the ELISA results (Fig. 12) . Normal cocultures, which, as shown, had significantly lower IFN-␥ secretion, were less influenced by HLA-DR blockade (up to 50% decrease in IFN-␥ secretion) ( Figs. 11A and 12) . Taken together, these data show that HLA-DR significantly contributes to CD4ϩ T cell stimulation by IBD IECs.
DISCUSSION
In this study we determined the potential of IECs to stimulate in vitro proliferation of and cytokine secretion by CD4ϩ T cells. Preferential stimulation of CD4ϩ T cells by IECs originating from IBD vs. normal tissue was demonstrated. This was best reflected by the observation of increased IFN-␥ secretion, which was significantly higher when CD4ϩ T cells were stimulated by IBD IECs compared with normal IECs. We also demonstrated that MHC class II molecules, which are increased on IBD IECs, mediate the interaction between IECs and CD4ϩ T cells. The data presented support the concept that IECs may be active participants in mucosal immune responses and suggest that IECs may bias T cell differentiation pathways either toward a controlled, regulated response in the normal state, or toward overactive immunity such as the uncontrolled inflammation seen in IBD.
We used cocultures of freshly isolated human IECs (from IBD patients and normal controls) with allogeneic normal PBTs to investigate the effects of IECs on T cells in mucosal homeostasis and intestinal inflammation. This in vitro model system allows us to focus on the differences in proliferation and cytokine secretion by T cells induced by nontransformed IECs, whereas the target population (normal PBTs) is kept constant. The T cell stimulation thus generated may reflect the situation in the intestinal mucosa more than maximal stimulation protocols such as phytohemagglutinin/PMA, or antibodies against the T cell receptor (TCR). Furthermore, the results produced by our coculture experiments are consistent with previous tissue-mRNA-and LPL-stimulation studies, thus adding validity to this model. Importantly, the proliferative responses induced by IECs were comparable in allogeneic as well as autologous normal T cells, as expected given the fact that these cells are CD1d restricted as previously reported (7). This supports our hypothesis that IBD IECs have an increased stimulatory effect on normal T cells and that this effect is not merely the result of an allogeneic response. Moreover, as shown in the crossover studies presented, the enhanced T cell stimulation seen in IBD is at the level of the IECs, rather than the T cells, as the proliferation pattern of PBT cells from IBD or normal patients related to the stimulating IEC source.
Previous studies have reported increases in local IFN-␥ production in tissues of patients with IBD (CD Ͼ UC). Increased IFN-␥ mRNA expression was demonstrated in mucosal samples from IBD patients compared with normal controls (46) , in chronic vs. early ileal lesions in CD patients (12) , in active and inactive CD lesions, and in specimens of pediatric CD patients compared with UC and normal controls (1, 4) . Increased IFN-␥ mRNA has also been demonstrated in tissues from UC patients (1, 25, 64) . Results obtained directly from tissues and analyzed for cytokine mRNA content are assumed to reflect the cytokine content within the tissue at that specific point in time. Although the strength of such studies is that they represent in vivo data, further analysis as to the source of the cytokine and the mechanisms involved in its production is not possible and mRNA expression does not necessarily reflect protein secretion. Other authors have, therefore, attempted to analyze cytokine profiles by immunohistochemical methods or by in vitro studies of LPLs. Similar results, i.e., increased IFN-␥ production, with or without various stimuli, have been documented. LPLs from CD patients demonstrated significantly increased intracellular IFN-␥ vs. LPLs from control patients (6) , and increased IFN-␥ secreting mononuclear cells were found in pediatric CD vs. UC and normal controls (4). CD4ϩ LPLs from CD patients secreted more IFN-␥ after stimulation via CD2/CD28 compared with UC or normal CD4ϩ LPLs (19) , and spontaneous release of IFN-␥ from cultured CD LPLs was also reported, in contrast to its absence in cultured normal LPLs (14) . Our finding of increased IFN-␥ secretion in IBD IEC stimulated CD4ϩ T cell cocultures suggest one possible mechanism for the findings reported in these previously published studies, which is that IECs from IBD patients are capable of triggering IFN-␥ secretion by CD4ϩ T cells. Do IBD IECs stimulate classic Th1 cells? The data presented here do not support this possibility. In general, whereas most studies have reported increased levels of IFN-␥ and Th1-promoting cytokines in IBD tissues (36) , results relating to IL-2 production are inconsistent, showing both increased (in CD) (4, 41, 46) , and decreased (30) levels in IBD vs. normal. In support of the latter observations, IL-2 levels Ͻ200 pg/ml were demonstrated in both IBD and normal cocultures. Moreover, when IBD IECs were the stimulator cells, IFN-␥ secretion by CD4ϩ T cells was ϳ70% of that seen in conventional mixed lymphocyte reactions (MLRs). In contrast, CD4ϩ T cell secretion of IL-2 was only ϳ20% of that seen in conventional MLRs (in the same cocultures) when the stimulator cells were IBD IECs. The discordant secretion of IL-2 and IFN-␥ raises further questions regarding classical Th1 cytokine profiles in the human intestinal mucosal immune system. Table 2 . In contrast to the mouse, in whom IL-10 deficiency is strongly associated with ileocolonic inflammation reminiscent of human CD (29) , in human IBD tissues IL-10 mRNA is reported to be increased rather than decreased (1, 25) . When attempts were made to identify the source of IL-10, IL-10 expression by LPLs was low. This was further supported by IL-10 mRNA and in vitro IL-10 secretion studies of LPLs from IBD patients (20) . In our study, IL-10 levels secreted in the cocultures were low, ϳ10% of those secreted in conventional MLRs. Nevertheless, higher mean values were demonstrated in normal IEC-stimulated CD4ϩ T cell cocultures (P Ͻ 0.0001 vs. UC IECs-stimulated IL-10 secretion by CD4ϩ T cells), hinting at a possible loss of tolerance in the inflamed epithelium vs. normal. Present data suggest that other suppressor cytokines such as TGF-␤ may also contribute to tolerance in the normal intestinal mucosal (8, 65) . However, we were unable to detect the presence of TGF-␤ mRNA in normal IEC:CD4ϩ T cell cocultures (data not shown).
By what mechanism do IECs stimulate CD4ϩ T cells? In a manner similar to their professional APC counterparts, the nonprofessional APCs, IECs, express several surface molecules that enable antigen presentation and lymphocyte stimulation. As these molecules are differentially expressed in normal and inflamed intestinal mucosa, this may explain the different CD4ϩ T cell subpopulation activation patterns seen. MHC class II molecules are constitutively expressed on normal IECs and their expression is increased on IBD epithelium (39) . The costimulatory molecule CD58 is found on normal epithelium whereas CD86 has been demonstrated only on UC epithelium (44, 43 ). An attractive hypothesis would therefore be that in the normal state CD4ϩ T cells are activated via TCR/CD3 by MHC class II molecules expressed on IECs. In IBD, stronger activation of TCR/CD3 by the increased levels of class II and CD2/CD28 by CD58/CD86 (in UC) molecules may shift CD4ϩ T cell subpopulations from relatively hypoproliferative cells that produce low levels of cytokines to proliferating, high-cytokine-secreting ones. In the present study we show that when HLA-DR expression on IBD IECs is blocked before coculture with CD4ϩ T cells a reduction of IFN-␥ production, as demonstrated by protein secretion and mRNA expression, is seen. Thus stimulation by class IIϩ IECs may be part of the mechanism of CD4ϩ T cell activation in IBD.
An interesting observation is that normal IECs are capable of stimulating CD4ϩ T cells to secrete a low but detectable amount of IFN-␥. The contribution of MHC class II molecules to normal IEC:CD4ϩ T cell interaction was less apparent than in IBD. This may suggest that other costimulatory molecules on normal IECs are responsible for IFN-␥ secretion by these cells and also that a low level of IFN-␥ may be important in normal mucosal homeostasis. The intriguing possibility that IFN-␥ is not always a proinflammatory cytokine is supported by studies reporting the regulatory effects that IFN-␥ has in models of inflammation and in oral tolerance induction in vitro and in vivo (16, 31, 32) . Thus it is tempting to speculate that IFN-␥ may also play a role in normal mucosal immunoregulation. There may be a fine line between the level of IFN-␥ required to maintain tolerance and the level required to promote active inflammation.
On the basis of the data presented in the present study, as well as previous work from our laboratory and others, we propose the following model for the interaction of normal IECs and lymphocytes ( Fig. 13) : Normal IECs predominantly activate CD8ϩ regulatory T cells via the MHC class I-like complex gp180:CD1d, which binds to CD8 and the TCR, respectively (7). CD8ϩ T cell proliferation and low-level IFN-␥ production ensue. These suppressor CD8ϩ T cells, together with CD4ϩ T regulatory cells already described in humans (26) , are responsible for the dominant suppressive tone in the healthy intestine, which may be mediated, in part, by IFN-␥. In IBD, gp180 expression on IECs is decreased, as reported previously (63) . This leads to the defective formation of the gp180:CD1d complex leading to decreased suppressor CD8ϩ T cell activation (38) . In parallel, the direct interaction of IECs with CD4ϩ T cells leads to increased CD4ϩ T cell activation resulting in increased proliferation and IFN-␥ secretion. This interaction, which is mediated by MHC class II molecules, as has been shown in the present study, may further contribute to skewing of the delicate balance between suppression and overactive immunity toward the latter. 
